4th Quarter - Report — SOLVENTUM CORPORATION for SOLVENTUM CORPORATION (2020)

Firm

SOLVENTUM CORPORATION

Client

SOLVENTUM CORPORATION

Income

—

Expenses

$80,000

Expense method

A: Lobbying Disclosure Act definitions

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

-Medicare and Medicaid payment quality programs and policies, including healthcare associated complications, infections, readmissions, payment bundling, potentially avoidable events, quality outcomes, transparency, site-neutral payment policy, and value-based payment policies -Medicare and Medicaid data, Medicaid Scorecards, health information exchanges (HIEs), interoperability, patient-centered medical records policies, and all-payer claims databases (APCDs) - Labor, Health and Human Services Appropriations - Public health initiatives related to COVID-19 -Implementation of the Patient Protection and Affordable Care Act (PL 111-148) -Implementation of the Helping Hospitals Improve Patient Care Act 21st Century Cures Act (Public Law No: 114-255) -Implementation of The Health Information Technology for Economic and Clinical Health Act (HITECH Act - part of the American Recovery and Reinvestment Act of 2009, PL 111-5) -Regulations and legislation related to International Classification of Diseases, version 10 (ICD-10) -S.317, ACE Kids Act -H.R. 1226, ACE Kids Act -S. 1895, Lower Health Care Costs Act -Healthcare Outcomes Act

Lobbyist	Covered position, as disclosed
MEGAN IVORY CARR	—

Contacted: SENATE; Office of the Vice President of the United States; Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES

Bills named: H.R. 1226 (116th), S. 1895 (116th), S. 317 (116th)

Medicare/Medicaid MMM

-Medicare and Medicaid payment quality programs and policies, including healthcare associated complications, infections, readmissions, payment bundling, potentially avoidable events, quality outcomes, transparency, site-neutral payment policy, and value-based payment policies -Medicare and Medicaid data, Medicaid Scorecards, health information exchanges (HIEs), interoperability, patient-centered medical records policies, and all-payer claims databases (APCDs) - Labor, Health and Human Services Appropriations - Public health initiatives related to COVID-19 -Implementation of the Patient Protection and Affordable Care Act (PL 111-148) -Implementation of the Helping Hospitals Improve Patient Care Act 21st Century Cures Act (Public Law No: 114-255) -Implementation of The Health Information Technology for Economic and Clinical Health Act (HITECH Act - part of the American Recovery and Reinvestment Act of 2009, PL 111-5). -Regulations and legislation related to International Classification of Diseases, version 10 (ICD-10) -S.317, ACE Kids Act -H.R. 1226, ACE Kids Act -S. 1895, Lower Health Care Costs Act -Healthcare Outcomes Act

Lobbyist	Covered position, as disclosed
MEGAN IVORY CARR	—

Contacted: Office of the Vice President of the United States; HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); SENATE

Bills named: S. 1895 (116th), S. 317 (116th), H.R. 1226 (116th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.